Andrew Mortlock

2.9k total citations · 1 hit paper
34 papers, 1.9k citations indexed

About

Andrew Mortlock is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Andrew Mortlock has authored 34 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Organic Chemistry, 10 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Andrew Mortlock's work include Microtubule and mitosis dynamics (7 papers), Synthetic Organic Chemistry Methods (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Andrew Mortlock is often cited by papers focused on Microtubule and mitosis dynamics (7 papers), Synthetic Organic Chemistry Methods (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Andrew Mortlock collaborates with scholars based in United Kingdom, United States and France. Andrew Mortlock's co-authors include Nicholas Keen, Trevor Johnson, Anthony Tighe, Stephen S. Taylor, Rebecca Ellston, Victoria Johnson, Stephen G. Davies, Frédéric Jung, Nicola M. Heron and Stephen Green and has published in prestigious journals such as Nucleic Acids Research, The Journal of Cell Biology and Blood.

In The Last Decade

Andrew Mortlock

33 papers receiving 1.9k citations

Hit Papers

Aurora B couples chromosome alignment with anaphase by ta... 2003 2026 2010 2018 2003 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores
    2003 980 citations Victoria Johnson, Anthony Tighe et al. The Journal of Cell Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Mortlock United Kingdom 18 1.3k 1.2k 702 351 196 34 1.9k
Daniella Zheleva United Kingdom 23 1.5k 1.2× 473 0.4× 830 1.2× 220 0.6× 188 1.0× 56 2.2k
Julian M.C. Golec United States 18 1.7k 1.3× 723 0.6× 1.1k 1.5× 247 0.7× 73 0.4× 24 2.3k
Michael A. Koldobskiy United States 14 1.7k 1.3× 326 0.3× 516 0.7× 213 0.6× 97 0.5× 26 2.3k
Vassilios Bavetsias United Kingdom 21 1.0k 0.8× 447 0.4× 471 0.7× 597 1.7× 31 0.2× 54 1.7k
Aurora O’Brate United States 22 1.1k 0.8× 549 0.4× 777 1.1× 585 1.7× 25 0.1× 37 1.9k
Stephen C. Cosenza United States 23 1.1k 0.9× 316 0.3× 571 0.8× 460 1.3× 40 0.2× 55 2.0k
Ulf Peters United States 12 2.4k 1.9× 460 0.4× 917 1.3× 517 1.5× 25 0.1× 17 3.0k
Jeremy Murray United States 22 1.4k 1.1× 270 0.2× 311 0.4× 204 0.6× 41 0.2× 36 1.8k
Butrus Atrash United Kingdom 18 767 0.6× 178 0.1× 323 0.5× 260 0.7× 21 0.1× 39 1.2k
Ian R. Hardcastle United Kingdom 31 1.8k 1.4× 253 0.2× 993 1.4× 1.1k 3.2× 37 0.2× 81 3.1k

Countries citing papers authored by Andrew Mortlock

Since Specialization
Citations

This map shows the geographic impact of Andrew Mortlock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Mortlock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Mortlock more than expected).

Fields of papers citing papers by Andrew Mortlock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Mortlock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Mortlock. The network helps show where Andrew Mortlock may publish in the future.

Co-authorship network of co-authors of Andrew Mortlock

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Mortlock. A scholar is included among the top collaborators of Andrew Mortlock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Mortlock. Andrew Mortlock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nuttall, Barrett, Daniel Karl, Kathleen A. Burke, et al.. (2025). Comprehensive comparison of enzymatic and bisulfite DNA methylation analysis in clinically relevant samples. Clinical Epigenetics. 17(1). 156–156.
2.
Roschewski, Mark, Manish R. Patel, Patrick M. Reagan, et al.. (2023). Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment. Clinical Cancer Research. 29(17). 3301–3312. 13 indexed citations
3.
Bradbury, Robert H., Neil J. Hales, Alfred A. Rabow, et al.. (2011). Small-molecule androgen receptor downregulators as an approach to treatment of advanced prostate cancer. Bioorganic & Medicinal Chemistry Letters. 21(18). 5442–5445. 36 indexed citations
4.
Foote, Kevin M., Andrew Mortlock, Nicola M. Heron, et al.. (2008). Synthesis and SAR of 1-acetanilide-4-aminopyrazole-substituted quinazolines: Selective inhibitors of Aurora B kinase with potent anti-tumor activity. Bioorganic & Medicinal Chemistry Letters. 18(6). 1904–1909. 32 indexed citations
5.
Bardelle, Catherine, Darren A.E. Cross, Sara Davenport, et al.. (2008). Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines. Bioorganic & Medicinal Chemistry Letters. 18(9). 2776–2780. 49 indexed citations
6.
Bardelle, Catherine, Tanya Coleman, Darren A.E. Cross, et al.. (2008). Inhibitors of the tyrosine kinase EphB4. Part 2: Structure-based discovery and optimisation of 3,5-bis substituted anilinopyrimidines. Bioorganic & Medicinal Chemistry Letters. 18(21). 5717–5721. 41 indexed citations
7.
Wilkinson, Robert W., Nicholas Keen, Rajesh Odedra, et al.. (2006). AZD1152: A highly potent and specific aurora kinase inhibitor.. Cancer Research. 66. 1333–1334. 6 indexed citations
8.
Heron, Nicola M., Malcolm Anderson, David P. Blowers, et al.. (2005). SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(5). 1320–1323. 101 indexed citations
9.
Mortlock, Andrew, Nicholas Keen, Frédéric Jung, et al.. (2005). Progress in the Development of Selective Inhibitors of Aurora Kinases. Current Topics in Medicinal Chemistry. 5(2). 199–213. 19 indexed citations
10.
Mortlock, Andrew, Nicholas Keen, Frédéric Jung, et al.. (2005). Progress in the Development of Selective Inhibitors of Aurora Kinases. Current Topics in Medicinal Chemistry. 5(8). 807–821. 62 indexed citations
11.
Mortlock, Andrew. (2003). Suppression of gene expression by a cell-permeable Tet repressor. Nucleic Acids Research. 31(23). 152e–152. 9 indexed citations
12.
Johnson, Victoria, Anthony Tighe, Rebecca Ellston, et al.. (2003). Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. The Journal of Cell Biology. 161(2). 267–280. 980 indexed citations breakdown →
13.
Armstrong, Alan, et al.. (1998). Synthesis of the Bicyclo[4.4.1]decenone Core of CP-225,917 and CP-263,114. Synlett. 1998(5). 552–553. 26 indexed citations
14.
15.
Dishington, Allan, et al.. (1997). Episulfone substitution and ring-opening reactions via α-sulfonyl carbanion intermediates. Journal of the Chemical Society Perkin Transactions 1. 323–338. 6 indexed citations
16.
Mortlock, Andrew, et al.. (1996). Total Syntheses of (−)-Papuamine and (−)-Haliclonadiamine. The Journal of Organic Chemistry. 61(2). 700–709. 35 indexed citations
17.
Davies, Stephen G. & Andrew Mortlock. (1992). Bifunctional chiral auxiliaries 4: Alkylation of enolates derived from 1,3-diacyl-trans-4,5-tetramethyleneimidazolidin-2-ones. Tetrahedron Letters. 33(8). 1117–1120. 13 indexed citations
18.
19.
20.
Davies, Stephen G. & Andrew Mortlock. (1991). Bifunctional chiral auxiliaries 1: the aldol reaction between dialkylboron enolates of 1,3-dipropionyl-trans-4,5-tetramethyleneimidazolidin-2-one and aldehydes. Tetrahedron Letters. 32(36). 4787–4790. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniella Zheleva Breakdown of academic impact, for papers by Julian M.C. Golec Breakdown of academic impact, for papers by Michael A. Koldobskiy Breakdown of academic impact, for papers by Vassilios Bavetsias Breakdown of academic impact, for papers by Aurora O’Brate Breakdown of academic impact, for papers by Stephen C. Cosenza Breakdown of academic impact, for papers by Ulf Peters Breakdown of academic impact, for papers by Jeremy Murray Breakdown of academic impact, for papers by Butrus Atrash Breakdown of academic impact, for papers by Ian R. Hardcastle
Rankless by CCL
2026